KLHL6 is a tumor suppressor gene in diffuse large B-cell lymphoma

References

• Gallo LH, Ko J, Donoghue DJ. The importance of regulatory ubiquitination in cancer and metastasis. Cell Cycle. 2017;16(7):634–648.
   PubMed Web of Science ®Google Scholar
• Tsukamoto S, Yokosawa H. Targeting the proteasome pathway. Expert Opin Ther Targets. 2009;13(5):605–621.
   PubMed Web of Science ®Google Scholar
• Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem. 1998;67:425–479.
   PubMed Web of Science ®Google Scholar
• Petroski MD, Deshaies RJ. Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol. 2005;6(1):9–20.
   PubMed Web of Science ®Google Scholar
• Cardozo T, Pagano M. The SCF ubiquitin ligase: insights into a molecular machine. Nat Rev Mol Cell Biol. 2004;5(9):739–751.
   PubMed Web of Science ®Google Scholar
• Skaar JR, Pagan JK, Pagano M. SnapShot: F box proteins II. Cell. 2009;137(7):1358, 1358 e1.
   PubMed Web of Science ®Google Scholar
• Erales J, Coffino P. Ubiquitin-independent proteasomal degradation. Biochim Biophys Acta. 2014;1843(1):216–221.
   PubMed Web of Science ®Google Scholar
• Genschik P, Sumara I, Lechner E. The emerging family of CULLIN3-RING ubiquitin ligases (CRL3s): cellular functions and disease implications. EMBO J. 2013;32(17):2307–2320.
   PubMed Web of Science ®Google Scholar
• Stogios PJ, Downs GS, Jauhal JJ, et al. Sequence and structural analysis of BTB domain proteins. Genome Biol. 2005;6(10):R82.
   PubMed Web of Science ®Google Scholar
• Zhuang M, Calabrese MF, Liu J, et al. Structures of SPOP-substrate complexes: insights into molecular architectures of BTB-Cul3 ubiquitin ligases. Mol Cell. 2009;36(1):39–50.
   PubMed Web of Science ®Google Scholar
• McMahon M, Thomas N, Itoh K, et al. Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a “tethering”mechanism: a two-site interaction model for the Nrf2-Keap1 complex. J Biol Chem. 2006;281(34):24756–24768.
   PubMed Web of Science ®Google Scholar
• Gupta-Rossi N, Storck S, Griebel PJ, et al. Specific over-expression of deltex and a new Kelch-like protein in human germinal center B cells. Mol Immunol. 2003;39(13):791–799.
   PubMed Web of Science ®Google Scholar
• Kroll J, Shi X, Caprioli A, et al. The BTB-kelch protein KLHL6 is involved in B-lymphocyte antigen receptor signaling and germinal center formation. Mol Cell Biol. 2005;25(19):8531–8540.
   PubMed Web of Science ®Google Scholar
• Bertocci B, Lecoeuche D, Sterlin D, et al. Klhl6 deficiency impairs transitional B cell survival and differentiation. J Immunol. 2017;199(7):2408–2420.
   PubMed Web of Science ®Google Scholar
• Young RM, Shaffer AL, Phelan JD, et al. B-cell receptor signaling in diffuse large B-cell lymphoma. Semin Hematol. 2015;52(2):77–85.
   PubMed Web of Science ®Google Scholar
• Puente XS, Pinyol M, Quesada V, et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature. 2011;475(7354):101–105.
   PubMed Web of Science ®Google Scholar
• Pasqualucci L, Neumeister P, Goossens T, et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature. 2001;412(6844):341–346.
   PubMed Web of Science ®Google Scholar
• Sutton L-A, Ljungström V, Mansouri L, et al. Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting. Haematologica. 2015;100(3):370–376.
   Web of Science ®Google Scholar
• Kim J.A., Hwang, B., Park, S. et al. Genomic profile of chronic lymphocytic leukemia in Korea identified by targeted sequencing. Plos One. 2016;11(12).
   Web of Science ®Google Scholar
• Morin R.D., Mendez-Lago M, Mungall AJ, et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature; 2011;476(7360):298–303.
   PubMed Web of Science ®Google Scholar
• Lohr JG, Stojanov P, Lawrence MS, et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci U S A. 2012;109(10):3879–3884.
   PubMed Web of Science ®Google Scholar
• Reddy A, Zhang J, Davis NS, et al. Genetic and functional drivers of diffuse large B cell lymphoma. Cell. 2017;171(2):481–494.e15.
   Web of Science ®Google Scholar
• Kunder CA, Roncador G, Advani RH, et al. KLHL6 is preferentially expressed in germinal center-derived B-cell lymphomas. Am J Clin Pathol. 2017;148(6):465–476.
   PubMed Web of Science ®Google Scholar
• Mareschal S, Pham-Ledard A, Viailly PJ, et al. identification of somatic mutations in primary cutaneous diffuse large B-cell lymphoma, leg type by massive parallel sequencing. J Invest Dermatol. 2017;137(9):1984–1994.
   PubMed Web of Science ®Google Scholar
• Weigert O, Kopp N, Lane AA, et al. Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation. Cancer Discov. 2012;2(1):47–55.
   PubMed Web of Science ®Google Scholar
• Ganapathi KA, Jobanputra V, Iwamoto F, et al. The genetic landscape of dural marginal zone lymphomas. Oncotarget. 2016;7(28):43052–43061.
   PubMedGoogle Scholar
• Teras LR, DeSantis CE, Cerhan JR et al. 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin. 2016;66(6):443–459.
   PubMed Web of Science ®Google Scholar
• Choi J, Lee K, Ingvarsdottir K, et al. Loss of KLHL6 promotes diffuse large B-cell lymphoma growth and survival by stabilizing the mRNA decay factor roquin2. Nat Cell Biol. 2018;20(5):586–596.
   PubMed Web of Science ®Google Scholar
• Leo Meriranta AP, Cervera A, Holte H Jr., et al. Sampsa Hautaniemi and Sirpa Leppä, low expression and somatic mutations of the KLHL6 gene predict poor survival in patients with activated B-cell like diffuse large B-cell lymphoma. Blood. 2016;128(22):2926.
   Web of Science ®Google Scholar
• Tang X, Orlicky S, Lin Z, et al. Suprafacial orientation of the SCFCdc4 dimer accommodates multiple geometries for substrate ubiquitination. Cell. 2007;129(6):1165–1176.
   Web of Science ®Google Scholar
• Anderson P. Intrinsic mRNA stability helps compose the inflammatory symphony. Nat Immunol. 2009;10(3):233–234.
   PubMed Web of Science ®Google Scholar
• Caput D, Beutler B, Hartog K, et al. Identification of a common nucleotide sequence in the 3’-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci U S A. 1986;83(6):1670–1674.
   PubMed Web of Science ®Google Scholar
• Hall TM. Multiple modes of RNA recognition by zinc finger proteins. Curr Opin Struct Biol. 2005;15(3):367–373.
   PubMed Web of Science ®Google Scholar
• Vinuesa CG, Cook MC, Angelucci C, et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature. 2005;435(7041):452–458.
   PubMed Web of Science ®Google Scholar
• Leppek K, Schott J, Reitter S, et al. Roquin promotes constitutive mRNA decay via a conserved class of stem-loop recognition motifs. Cell. 2013;153(4):869–881.
   PubMed Web of Science ®Google Scholar
• Schlundt A, Heinz GA, Janowski R, et al. Structural basis for RNA recognition in roquin-mediated post-transcriptional gene regulation. Nat Struct Mol Biol. 2014;21(8):671–678.
   PubMed Web of Science ®Google Scholar
• Tan D, Zhou M, Kiledjian M, et al. The ROQ domain of Roquin recognizes mRNA constitutive-decay element and double-stranded RNA. Nat Struct Mol Biol. 2014;21(8):679–685.
   PubMed Web of Science ®Google Scholar
• Bertossi A, Aichinger M, Sansonetti P, et al. Loss of Roquin induces early death and immune deregulation but not autoimmunity. J Exp Med. 2011;208(9):1749–1756.
   PubMed Web of Science ®Google Scholar
• Heissmeyer V, Vogel KU. Molecular control of Tfh-cell differentiation by Roquin family proteins. Immunol Rev. 2013;253(1):273–289.
   PubMedGoogle Scholar
• Vogel KU, Edelmann SL, Jeltsch KM, et al. Roquin paralogs 1 and 2 redundantly repress the Icos and Ox40 costimulator mRNAs and control follicular helper T cell differentiation. Immunity. 2013;38(4):655–668.
   PubMed Web of Science ®Google Scholar
• Glasmacher E, Hoefig KP, Vogel KU, et al. Roquin binds inducible costimulator mRNA and effectors of mRNA decay to induce microRNA-independent post-transcriptional repression. Nat Immunol. 2010;11(8):725–733.
   PubMed Web of Science ®Google Scholar
• Yu D, Tan AH-M, Hu X, et al. Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature. 2007;450(7167):299–303.
   PubMed Web of Science ®Google Scholar
• Pratama A, Ramiscal RR, Silva DG, et al. Roquin-2 shares functions with its paralog Roquin-1 in the repression of mRNAs controlling T follicular helper cells and systemic inflammation. Immunity. 2013;38(4):669–680.
   PubMed Web of Science ®Google Scholar
• Choi J, Saraf A, Florens L, et al. PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. Cell Cycle. 2018;17(18):2243–2255..
   PubMed Web of Science ®Google Scholar
• Staudt, LM, Oncogenic activation of NF-kappaB. Cold Spring Harb Perspect Biol, 2010;2(6):a000109.
   PubMed Web of Science ®Google Scholar
• Lenz G, Davis RE, Ngo VN, et al. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science. 2008;319(5870):1676–1679.
   PubMed Web of Science ®Google Scholar
• Davis RE, Ngo VN, Lenz G, et al. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature. 2010;463(7277):88–92.
   PubMed Web of Science ®Google Scholar
• Compagno M, Lim WK, Grunn A, et al. Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature. 2009;459(7247):717–721.
   PubMed Web of Science ®Google Scholar
• Kato M, Sanada M, Kato I, et al. Frequent inactivation of A20 in B-cell lymphomas. Nature. 2009;459(7247):712–716.
   PubMed Web of Science ®Google Scholar
• Lenz G, Wright G, Dave SS, et al. Stromal gene signatures in large-B-cell lymphomas. N Engl J Med. 2008;359(22):2313–2323.
   PubMed Web of Science ®Google Scholar
• Murakawa Y, Hinz M, Mothes J, et al. RC3H1 post-transcriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-κB pathway. Nat Commun. 2015;6:7367.
   PubMed Web of Science ®Google Scholar
• Wertz IE, O’Rourke KM, Zhou H, et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature. 2004;430(7000):694–699.
   PubMed Web of Science ®Google Scholar
• Bosanac I, Wertz IE, Pan B, et al. Ubiquitin binding to A20 ZnF4 is required for modulation of NF-κB signaling. Mol Cell. 2010;40(4):548–557.
   PubMed Web of Science ®Google Scholar
• Skaug B, Chen J, Du F, et al. Direct, noncatalytic mechanism of IKK inhibition by A20. Mol Cell. 2011;44(4):559–571.
   PubMed Web of Science ®Google Scholar
• Novak U, Rinaldi A, Kwee I, et al. The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas. Blood. 2009;113(20):4918–4921.
   PubMed Web of Science ®Google Scholar
• Chapman MA, Lawrence MS, Keats JJ, et al. Initial genome sequencing and analysis of multiple myeloma. Nature. 2011;471(7339):467–472.
   PubMed Web of Science ®Google Scholar